1357576-00-1Relevant articles and documents
NANOPARTICLE FORMULATION OF BCL-2 INHIBITOR
-
Paragraph 0377; 0379, (2021/01/29)
Various albumin nanoparticle Bcl-2 inhibitor formulations are described, along with methods of using them to treat conditions characterized by excessive cellular proliferation, such as cancer and tumors. In various embodiments, such Bcl-2 inhibitor formulations contain albumin and a compound of the following Formula (I), or a pharmaceutically acceptable salt thereof, where the variables in Formula (I) are defined herein.